# Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period

> **NCT05135104** · — · UNKNOWN · sponsor: **Asociatia Oncohelp - Centrul de Oncologie Oncohelp** · enrollment: 650 (estimated)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Palbociclib

## Key facts

- **NCT ID:** NCT05135104
- **Lead sponsor:** Asociatia Oncohelp - Centrul de Oncologie Oncohelp
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-15
- **Primary completion:** 2024-03-25
- **Final completion:** 2024-05-25
- **Target enrollment:** 650 (ESTIMATED)
- **Last updated:** 2023-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05135104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05135104, "Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05135104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*